查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年藥用輔料市場預測：按產品、功能、給藥途徑、配銷通路、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1324205

2030 年藥用輔料市場預測：按產品、功能、給藥途徑、配銷通路、最終用戶和地區進行的全球分析

Pharmaceutical Excipients Market Forecasts to 2030 - Global Analysis By Product, Functionality, Route of Administration, Distribution Channel End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球藥用輔料市場規模為 92 億美元，預計到 2030 年將達到 158 億美元，預測期內年複合成長率為 7.9%。

賦形劑已經以多種方式被描述，包括用作藥物稀釋劑或載體的惰性材料。這種解釋的問題在於，最近已經清楚地表明賦形劑不是惰性的，可以與患者以及配方中的其他成分發生反應，可能導致不愉快和過敏反應。這是事實。這些可能會導致從輕微皮疹到致命反應的任何情況。不同的添加劑，特別是防腐劑和色素，可能存在於同一藥物的多個品牌中。

根據歐洲製藥工業協會聯合會2022年報告，2020年歐洲地區藥品產值為2866.97億歐元，2021年為3000億歐元。

增加學名藥的生產和使用

美國國家生物技術資訊中心（NCBI）和美國食品藥物管理局（FDA）決定增加學名藥數量，將學名藥定義為在劑型、安全性、強度、給藥途徑等方面具有不同特徵的藥物、品質和性能。它被定義為與已批准的品牌藥物相似的藥物。使用學名藥所節省的成本並不會因為藥物的專利過期而立即顯現出來。與品牌藥一樣，學名藥也需要學名藥市場的競爭來降低成本。由於印度的人均醫療保健支出最高，這些學名藥將有助於降低成本。近年來，學名藥的使用在全國範圍內急劇擴大。此外，由於學名藥價格低廉，因此被頻繁使用，從而推動了市場成長。

品質和安全問題

儘管賦形劑在藥品中的使用正在擴大，但該行業仍然難以滿足法規、消費者、藥品製造商和患者設定的高標準。藥效和重要的品質屬性受到輔料製造變化的影響。不同供應商和批次之間賦形劑的差異可能會影響賦形劑與藥物的相互作用，進而影響藥物。大多數藥用輔料的製造是由低成本國家的小公司進行的。由於對積層製造程序和品質的控制水平有限，確保整個供應鏈的工藝透明度比以往任何時候都更加重要。

增加多功能添加劑

多用途賦形劑是一種新方法，可解決藥物上市平均需要 10 至 12 年的漫長而用途的過程。多功能添加劑可改善整個製藥過程中的流動性、可壓縮性、生物利用度和粒度分佈。其好處有很多，包括提高生產率、降低成本、加快製造速度、創造新化學品以及配製 ODT。多功能添加劑有助於最佳化研究並協助解決配方開發問題。目前大多數市場參與者都專注於開發現有輔料的新等級，以提高特定用途的性能，例如口腔崩解錠片輔料、控釋製劑、速釋製劑和外用製劑。

有關藥物和輔料核准的更嚴格法規

各國學名藥的核准流程基本相同，但欠已開發國家略有差異。這是因為生物等效性 (BE) 研究在該地區被豁免。衛生相關人員表示，政府必須確保所有學名藥的品質統一。只有這樣，醫生才能滿意、有信心地開學名藥處方。缺乏圍繞學名藥數量和允許污染物數量的強力的法規標準是醫生對學名藥不信任的一個關鍵要素。此外，由於新型賦形劑和遞送方法的開發，在體內活性的背景下，改進對藥物賦形劑的供應和品質的控制變得更加重要。

COVID-19 的影響：

COVID-19 大流行對製藥行業產生了重大負面影響。疫情導致的封鎖措施阻止了來自中國和印度等擁有大型工業基地的國家的原料流動。這減緩了藥物研究和製造，對嚴重依賴外包的企業產生了負面影響。整個醫藥生態系統首先被顛覆。為了保證患者用藥後最高水平的安全，法規機構不得不不斷制定新的法律。停工結束後，由於對羥氯喹和瑞德西韋等有效對抗 COVID-19 的藥物需求增加，製藥行業恢復生機。

預計有機化學品行業在預測期內將是最大的

由於有機化合物無毒並且可以作為口服藥物製劑中的添加劑，因此有機化學品領域預計將出現良好的成長。石化產品、碳水化合物、石化產品、蛋白質和其他有機化學品結構了有機化學品市場的以下五個主要部分：鑑於碳是所有生物的結構要素，有機分子極其重要。有機分子是許多推動地球運動的循環的基本組成部分。以碳循環為例，碳在光合作用和細胞呼吸過程中在植物和動物之間轉移。

粘合劑細分市場預計在預測期內年複合成長率最高

預計粘合劑市場在預測期內年複合成長率最高。由於藥品和生物製藥的需求不斷增加以及新產品的推出，預計粘合劑類別在預測期內將出現大幅擴張。隨著時間的推移，製藥行業逐漸認知到粘合劑可以提高活性化合物的性能並提供競爭優勢。此外，隨著藥品產量的增加，對粘合劑的需求預計也會增加，這預計將刺激該領域的擴張。尖端原創產品的推出正在加速該細分市場的成長。

佔比最大的地區

由於製藥行業迅速擴張、功能性輔料需求不斷成長、同一領域存在重要競爭、技術進步等，預計北美將在預測期內佔據最大的市場佔有率，所有這些預計都將佔據最大的市場佔有率。為預測期內最大的市場佔有率，將為整個預測期內的市場成長做出重大貢獻。新的軟膠囊混合物為生產商提供了一種簡單易用的選擇，確保製藥和營養補充食品的快速和可重複的放大。此類新品的推出為市場提供了更多前沿產品，刺激了市場擴張。

複合年複合成長率最高的地區：

預計歐洲在預測期內的年複合成長率最高。這是因為藥品專利即將到期，歐洲多個國家都在關注學名藥行業。因此，德國、英國和法國等歐洲國家預計在預測期內將出現顯著的成長。預計這將增加該地區對藥用輔料的需求。此外，這些國家的學名藥市場預計將受到政府擴大降低市場藥品價格舉措的推動。

免費客製化服務：

訂閱此報告的客戶將收到以下免費客製化選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（注：基於可行性檢查）
  • 競爭標杆管理
    • 根據產品系列、地域分佈和戰略聯盟對主要企業進行基準測試

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 資料挖掘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 假設

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球藥用輔料市場：副產品

  • 有機化學品
    • 碳水化合物
      • 砂糖
      • 實際糖
      • 人造甜味劑
      • 糖醇
      • 澱粉
      • 修飾澱粉
      • 干淀粉
      • 修飾澱粉
      • 纖維素
      • 羧甲基纖維素
      • 纖維素酯
      • 纖維素醚
      • 結晶質纖維素
    • 石化產品
      • 丙烯酸聚合物
      • 明膠
      • 乙二醇
      • 礦物碳氫化合物
      • 油脂化學品
      • 波維東斯
      • 其他石化產品
    • 蛋白質
    • 其他有機化學品
  • 油脂化學品
    • 硬脂酸金屬鹽
    • 脂肪醇
    • 甘油
    • 其他油脂化學品
  • 無機化學品 酒精
    • 碳酸鈣
    • 磷酸鈣
    • 硫酸鈣
    • 岩鹽
    • 金屬氧化物
    • 其他無機化學品
  • 其他產品

第6章 全球藥用輔料市場：按功能分類

  • 消泡劑
  • 抗氧化劑
  • 活頁夾
  • 緩衝
  • 螯合劑
  • 塗層
  • 著色劑
  • 崩壞
  • 潤膚劑
  • 乳化劑
  • 填充劑和稀釋劑
  • 調味劑和甜味劑
  • 潤滑劑和助流劑
  • 防腐劑
  • 溶劑
  • 吸附劑
  • 懸浮劑和增粘劑
  • 其他

第7章 全球藥用輔料市場：按給藥途徑分類

  • 口服
  • 胃腸外的
  • 外用
  • 腸內的
  • 舌下/頰
  • 肌肉注射
  • 靜脈
  • 其他

第8章 全球藥用輔料市場：按配銷通路分類

  • 零售銷售
  • 直接投標
  • 網上藥房
  • 其他配銷通路

第9章 全球藥用輔料市場：按最終用戶分類

  • 學術的
  • 契約策劃師
  • 製藥公司
  • 研究機構
  • 其他最終用戶

第10章 全球藥用輔料市場：按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章進展

  • 契約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章公司簡介

  • Evonik Industries AG
  • Kerry
  • BASF SE
  • Innophos
  • Archer Daniels Midland Company
  • Air Liquide group
  • Associated British Foods PLC
  • Croda International PLC
  • Roquette Freres
  • The Lubrizol Corporation
  • DuPont
  • Ashland
  • International Flavors & Fragrances, Inc.
  • FMC Corporation
  • The Dow Chemicals Company
  • Akzo Nobel NV
  • Crode International PLC
  • Ferro Corporation
Product Code: SMRC23483

According to Stratistics MRC, the Global Pharmaceutical Excipients Market is accounted for $9.2 billion in 2023 and is expected to reach $15.8 billion by 2030 growing at a CAGR of 7.9% during the forecast period. Excipients have been described in a variety of ways, including as inert materials employed as medication diluents and carriers. The issue with this description is that excipients have recently shown themselves to be anything from inert, being capable of reacting not only with other components in the formulation but also with patients, leading to unpleasant and hypersensitive responses. These can cause anything from a little rash to a response that might be fatal. Different excipients, particularly preservatives and colourants, may be present in several brands of the same medication.

According to the European Federation of Pharmaceutical Industries and Associations, 2022 report, the production of pharmaceuticals in the European region was valued at EUR 286,697 million in 2020 and EUR 300,000 million in 2021.

Market Dynamics:

Driver:

Increasing production and use of generic drugs

The National Centre for Biotechnology Information (NCBI) and the U.S. Food and Drug Administration (FDA) have decided to increase the generic medication and they define a generic drug as a medication that has been produced to resemble an authorised brand-name medication in terms of dosage form, safety, and strength, route of administration, quality, and performance. The cost reductions linked to using common drugs are not immediately evident when the drug's patent expires. Generic pharmaceuticals, like brand-name drugs, need competition in the generic drug market before costs may be reduced. These generic medicines would save money because India has the greatest per-capita spending. The usage of generic medications has dramatically expanded nationwide in recent years. Additionally, because generic medications are less expensive, they are used more frequently thus propelling the growth of the market.

Restraint:

Concerns about quality and safety

Despite the expanding usage of excipients in medicines, the industry still has a difficult time living up to the high standards set by regulators, consumers, medication manufacturers, and patients. The efficacy and vital quality characteristics of the medicine are impacted by variations in excipient manufacture. Excipient variability from supplier to supplier or batch to batch influences the excipient-drug interaction, which in turn affects the drug. Smaller businesses in low-cost nations handle a significant portion of the manufacturing of pharmaceutical excipients. Due to the limited level of control over the excipient manufacturing process and quality, process transparency throughout the whole supply chain is now more important than ever.

Opportunity:

Increase in multifunctional excipients

Excipients with numerous uses have been developed as a fresh approach to the lengthy and expensive process of bringing a medicine to market, which can take, on average, 10 to 12 years. Multifunctional excipients increase flowability, compressibility, bioavailability, and particle size distribution throughout the medication production process. They have a number of benefits, including increased productivity, lower costs, faster manufacturing, the creation of novel chemical entities, and the formulation of ODT. Multifunctional excipients will make optimisation studies easier and aid with formulation development problems. To enhance their performance for certain applications, such as excipients for orally disintegrating tablets, controlled-release formulations, immediate-release applications, and topical formulations, the majority of market companies are currently concentrating on developing new grades of existing excipients.

Threat:

Increasing regulatory stringency for drug and excipient approval

The procedures for approving generic drugs are essentially the same everywhere, with very minor variations in underdeveloped nations. This is due to the fact that he is exempt from the bioequivalence (BE) research requirement in this region of the world. Medical professionals assert that governments must guarantee the uniform quality of all generic medications. Only then can physicians be content and confident in writing generic medicine prescriptions. The lack of strong regulatory criteria surrounding the number of generic pharmaceuticals and the number of allowable contaminants has been a key factor in physician's lack of faith in generic medications. Furthermore, improved management of the supply and quality of pharmaceutical excipients has become more crucial in the context of in vivo activity as a result of the development of novel excipients and delivery methods.

COVID-19 Impact:

The COVID-19 pandemic has had a significant negative impact on the pharmaceutical sector. Lockdowns implemented as a result of the outbreak have stopped the flow of raw materials from countries with large industrial bases, such China and India. This adversely affected businesses that significantly depended on outsourcing by slowing down the research and manufacture of pharmaceuticals. The whole pharmaceutical ecosystem was first upended. In order to assure the highest level of patient safety following drug use, regulatory bodies had to continually craft new legislation. After the shutdowns were over, the pharmaceutical sector took up, thanks in large part to the increased demand for medications like hydroxyl chloroquine and Remdesivir that were effective against COVID-19.

The organic chemicals segment is expected to be the largest during the forecast period

The organic chemicals segment is estimated to have a lucrative growth, due to the fact that organic compounds are non-toxic and work well as excipients in oral medication formulations. Oil chemicals, carbohydrates, petrochemicals, proteins, and other organic chemicals make up the next five key divisions of the market for organic chemicals. Given that carbon is a component of all living things, organic molecules are crucial. They are the fundamental parts of a lot of the earth-moving cycles. Take the carbon cycle as an illustration, which involves the transfer of carbon between plants and animals during photosynthesis and cellular respiration.

The binders segment is expected to have the highest CAGR during the forecast period

The binders segment is anticipated to witness the highest CAGR growth during the forecast period, due to the rising demand for pharmaceutical and biopharmaceutical medications as well as the introduction of new products, the binders category is anticipated to have considerable expansion throughout the projected period. Over time, the pharmaceutical industry has come to understand that binders may help active medicinal compounds perform better and provide them a competitive edge. Additionally, the need for binders is anticipated to rise along with the increase in pharmaceutical output, which is anticipated to fuel the segment's expansion. The introduction of cutting-edge and creative items is accelerating the market segment's growth.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the rapidly expanding pharmaceutical sector, rising demand for functional excipients, the existence of significant competitors in the area, and technological improvements will all significantly contribute to the market's growth throughout the forecast period. The new soft gel mix offers producers a simple, handy option that guarantees quick, repeatable scale-up for both pharmaceutical and nutraceuticals applications. Such new launches provide more cutting-edge items to the market, which stimulates market expansion.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to the imminent expiration of the drug patents, several European nations are concentrating on the generics industry. As a result, considerable growth rates in European nations like Germany, the United Kingdom, France, and others are predicted to occur throughout the projection period. This is projected to increase demand for pharmaceutical excipients in the area. Additionally, it is projected that the market for generic medications in these nations would be driven by the expanding government initiatives for lowering the prices of the drugs on the market.

Key players in the market

Some of the key players profiled in the Pharmaceutical Excipients Market include: Evonik Industries AG, KerryBASF SE, Innophos, Archer Daniels Midland Company, Air Liquide group, Associated British Foods PLC, Croda International PLC, Roquette Freres, The Lubrizol Corporation, DuPont, Ashland, International Flavors & Fragrances, Inc., FMC Corporation, The Dow Chemicals Company, Akzo Nobel NV, Crode International PLC and Ferro Corporation

Key Developments:

In June 2023, Evonik company, launches the wound dressing epicite® balance onto the German market. Available from June 2023, the dressing is particularly suited and optimized for the treatment of chronic wounds with low to medium exudation.

In May 2019, Ashland launched the Aquaflow NMS 460E rheology modifier, a nonionic synthetic associative thickener.

In May 2019, Colorcon launched STARTAB, a new starch tableting excipient designed specifically for the direct compression process.

Products Covered:

  • Organic Chemicals
  • Oleochemicals
  • Inorganic Chemicals
  • Other Products

Functionalities Covered:

  • Antifoaming Agents
  • Antioxidants
  • Binders
  • Buffers
  • Chelating Agents
  • Coatings
  • Colorants
  • Disintegrants
  • Emollients
  • Emulsifying Agents
  • Fillers and Diluents
  • Flavoring Agents & Sweeteners
  • Lubricants and Glidants
  • Preservatives
  • Solvents
  • Sorbents
  • Suspension and Viscosity Agents
  • Other Functionalities

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Topical
  • Enteral
  • Sublingual & Buccal
  • Intramuscular
  • Intravenous
  • Other Route of Administrations

Distribution Channels Covered:

  • Retail Sales
  • Direct Tender
  • Online Pharmacy
  • Other Distribution Channels

End Users Covered:

  • Academics
  • Contract Formulators
  • Pharmaceuticals Companies
  • Research Organization
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Excipients Market, By Product

  • 5.1 Introduction
  • 5.2 Organic Chemicals
    • 5.2.1 Carbohydrates
      • 5.2.1.1 Sugars
      • 5.2.1.1.1 Actual Sugars
      • 5.2.1.1.2 Artificial Sweetners
      • 5.2.1.1.3 Sugar Alcohols
      • 5.2.1.2 Starches
      • 5.2.1.2.1 Converted Starch
      • 5.2.1.2.2 Dried Starch
      • 5.2.1.2.3 Modified Starch
      • 5.2.1.3 Cellulose
      • 5.2.1.3.1 Carboxymethyl cellulose
      • 5.2.1.3.2 Cellulose esters
      • 5.2.1.3.3 Cellulose ethers
      • 5.2.1.3.4 Microcrystalline cellulose
    • 5.2.2 Petrochemicals
      • 5.2.2.1 Acrylic Polymers
      • 5.2.2.2 Gelatin
      • 5.2.2.3 Glycols
      • 5.2.2.4 Mineral Hydrocarbons
      • 5.2.2.5 Oleochemicals
      • 5.2.2.6 Povidones
      • 5.2.2.7 Other Petrochemicals
    • 5.2.3 Proteins
    • 5.2.4 Other Organic Chemicals
  • 5.3 Oleochemicals
    • 5.3.1 Metal Stearates
    • 5.3.2 Fatty Alcohols
    • 5.3.3 Glycerin
    • 5.3.4 Other Oleochemicals
  • 5.4 Inorganic Chemicals Alcohols
    • 5.4.1 Calcium Carbonate
    • 5.4.2 Calcium Phosphate
    • 5.4.3 Calcium Sulfate
    • 5.4.4 Halites
    • 5.4.5 Metal Oxides
    • 5.4.6 Other Inorganic Chemicals
  • 5.5 Other Products

6 Global Pharmaceutical Excipients Market, By Functionality

  • 6.1 Introduction
  • 6.2 Antifoaming Agents
  • 6.3 Antioxidants
  • 6.4 Binders
  • 6.5 Buffers
  • 6.6 Chelating Agents
  • 6.7 Coatings
  • 6.8 Colorants
  • 6.9 Disintegrants
  • 6.10 Emollients
  • 6.11 Emulsifying Agents
  • 6.12 Fillers and Diluents
  • 6.13 Flavoring Agents & Sweeteners
  • 6.14 Lubricants and Glidants
  • 6.15 Preservatives
  • 6.16 Solvents
  • 6.17 Sorbents
  • 6.18 Suspension and Viscosity Agents
  • 6.19 Other Functionalities

7 Global Pharmaceutical Excipients Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Topical
  • 7.5 Enteral
  • 7.6 Sublingual & Buccal
  • 7.7 Intramuscular
  • 7.8 Intravenous
  • 7.9 Other Route of Administrations

8 Global Pharmaceutical Excipients Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Retail Sales
  • 8.3 Direct Tender
  • 8.4 Online Pharmacy
  • 8.5 Other Distribution Channels

9 Global Pharmaceutical Excipients Market, By End User

  • 9.1 Introduction
  • 9.2 Academics
  • 9.3 Contract Formulators
  • 9.4 Pharmaceuticals Companies
  • 9.5 Research Organization
  • 9.6 Other End Users

10 Global Pharmaceutical Excipients Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Evonik Industries AG
  • 12.2 Kerry
  • 12.3 BASF SE
  • 12.4 Innophos
  • 12.5 Archer Daniels Midland Company
  • 12.6 Air Liquide group
  • 12.7 Associated British Foods PLC
  • 12.8 Croda International PLC
  • 12.9 Roquette Freres
  • 12.10 The Lubrizol Corporation
  • 12.11 DuPont
  • 12.12 Ashland
  • 12.13 International Flavors & Fragrances, Inc.
  • 12.14 FMC Corporation
  • 12.15 The Dow Chemicals Company
  • 12.16 Akzo Nobel NV
  • 12.17 Crode International PLC
  • 12.18 Ferro Corporation

List of Tables

  • Table 1 Global Pharmaceutical Excipients Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pharmaceutical Excipients Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Pharmaceutical Excipients Market Outlook, By Organic Chemicals (2021-2030) ($MN)
  • Table 4 Global Pharmaceutical Excipients Market Outlook, By Carbohydrates (2021-2030) ($MN)
  • Table 5 Global Pharmaceutical Excipients Market Outlook, By Sugars (2021-2030) ($MN)
  • Table 6 Global Pharmaceutical Excipients Market Outlook, By Actual Sugars (2021-2030) ($MN)
  • Table 7 Global Pharmaceutical Excipients Market Outlook, By Artificial Sweetners (2021-2030) ($MN)
  • Table 8 Global Pharmaceutical Excipients Market Outlook, By Sugar Alcohols (2021-2030) ($MN)
  • Table 9 Global Pharmaceutical Excipients Market Outlook, By Starches (2021-2030) ($MN)
  • Table 10 Global Pharmaceutical Excipients Market Outlook, By Converted Starch (2021-2030) ($MN)
  • Table 11 Global Pharmaceutical Excipients Market Outlook, By Dried Starch (2021-2030) ($MN)
  • Table 12 Global Pharmaceutical Excipients Market Outlook, By Modified Starch (2021-2030) ($MN)
  • Table 13 Global Pharmaceutical Excipients Market Outlook, By Cellulose (2021-2030) ($MN)
  • Table 14 Global Pharmaceutical Excipients Market Outlook, By Carboxymethyl cellulose (2021-2030) ($MN)
  • Table 15 Global Pharmaceutical Excipients Market Outlook, By Cellulose esters (2021-2030) ($MN)
  • Table 16 Global Pharmaceutical Excipients Market Outlook, By Cellulose ethers (2021-2030) ($MN)
  • Table 17 Global Pharmaceutical Excipients Market Outlook, By Microcrystalline cellulose (2021-2030) ($MN)
  • Table 18 Global Pharmaceutical Excipients Market Outlook, By Petrochemicals (2021-2030) ($MN)
  • Table 19 Global Pharmaceutical Excipients Market Outlook, By Acrylic Polymers (2021-2030) ($MN)
  • Table 20 Global Pharmaceutical Excipients Market Outlook, By Gelatin (2021-2030) ($MN)
  • Table 21 Global Pharmaceutical Excipients Market Outlook, By Glycols (2021-2030) ($MN)
  • Table 22 Global Pharmaceutical Excipients Market Outlook, By Mineral Hydrocarbons (2021-2030) ($MN)
  • Table 23 Global Pharmaceutical Excipients Market Outlook, By Oleochemicals (2021-2030) ($MN)
  • Table 24 Global Pharmaceutical Excipients Market Outlook, By Povidones (2021-2030) ($MN)
  • Table 25 Global Pharmaceutical Excipients Market Outlook, By Other Petrochemicals (2021-2030) ($MN)
  • Table 26 Global Pharmaceutical Excipients Market Outlook, By Proteins (2021-2030) ($MN)
  • Table 27 Global Pharmaceutical Excipients Market Outlook, By Other Organic Chemicals (2021-2030) ($MN)
  • Table 28 Global Pharmaceutical Excipients Market Outlook, By Oleochemicals (2021-2030) ($MN)
  • Table 29 Global Pharmaceutical Excipients Market Outlook, By Metal Stearates (2021-2030) ($MN)
  • Table 30 Global Pharmaceutical Excipients Market Outlook, By Fatty Alcohols (2021-2030) ($MN)
  • Table 31 Global Pharmaceutical Excipients Market Outlook, By Glycerin (2021-2030) ($MN)
  • Table 32 Global Pharmaceutical Excipients Market Outlook, By Other Oleochemicals (2021-2030) ($MN)
  • Table 33 Global Pharmaceutical Excipients Market Outlook, By Inorganic Chemicals (2021-2030) ($MN)
  • Table 34 Global Pharmaceutical Excipients Market Outlook, By Alcohols (2021-2030) ($MN)
  • Table 35 Global Pharmaceutical Excipients Market Outlook, By Calcium Carbonate (2021-2030) ($MN)
  • Table 36 Global Pharmaceutical Excipients Market Outlook, By Calcium Phosphate (2021-2030) ($MN)
  • Table 37 Global Pharmaceutical Excipients Market Outlook, By Calcium Sulfate (2021-2030) ($MN)
  • Table 38 Global Pharmaceutical Excipients Market Outlook, By Halites (2021-2030) ($MN)
  • Table 39 Global Pharmaceutical Excipients Market Outlook, By Metal Oxides (2021-2030) ($MN)
  • Table 40 Global Pharmaceutical Excipients Market Outlook, By Other Inorganic Chemicals (2021-2030) ($MN)
  • Table 41 Global Pharmaceutical Excipients Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 42 Global Pharmaceutical Excipients Market Outlook, By Functionality (2021-2030) ($MN)
  • Table 43 Global Pharmaceutical Excipients Market Outlook, By Antifoaming Agents (2021-2030) ($MN)
  • Table 44 Global Pharmaceutical Excipients Market Outlook, By Antioxidants (2021-2030) ($MN)
  • Table 45 Global Pharmaceutical Excipients Market Outlook, By Binders (2021-2030) ($MN)
  • Table 46 Global Pharmaceutical Excipients Market Outlook, By Buffers (2021-2030) ($MN)
  • Table 47 Global Pharmaceutical Excipients Market Outlook, By Chelating Agents (2021-2030) ($MN)
  • Table 48 Global Pharmaceutical Excipients Market Outlook, By Coatings (2021-2030) ($MN)
  • Table 49 Global Pharmaceutical Excipients Market Outlook, By Colorants (2021-2030) ($MN)
  • Table 50 Global Pharmaceutical Excipients Market Outlook, By Disintegrants (2021-2030) ($MN)
  • Table 51 Global Pharmaceutical Excipients Market Outlook, By Emollients (2021-2030) ($MN)
  • Table 52 Global Pharmaceutical Excipients Market Outlook, By Emulsifying Agents (2021-2030) ($MN)
  • Table 53 Global Pharmaceutical Excipients Market Outlook, By Fillers and Diluents (2021-2030) ($MN)
  • Table 54 Global Pharmaceutical Excipients Market Outlook, By Flavoring Agents & Sweeteners (2021-2030) ($MN)
  • Table 55 Global Pharmaceutical Excipients Market Outlook, By Lubricants and Glidants (2021-2030) ($MN)
  • Table 56 Global Pharmaceutical Excipients Market Outlook, By Preservatives (2021-2030) ($MN)
  • Table 57 Global Pharmaceutical Excipients Market Outlook, By Solvents (2021-2030) ($MN)
  • Table 58 Global Pharmaceutical Excipients Market Outlook, By Sorbents (2021-2030) ($MN)
  • Table 59 Global Pharmaceutical Excipients Market Outlook, By Suspension and Viscosity Agents (2021-2030) ($MN)
  • Table 60 Global Pharmaceutical Excipients Market Outlook, By Other Functionalities (2021-2030) ($MN)
  • Table 61 Global Pharmaceutical Excipients Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 62 Global Pharmaceutical Excipients Market Outlook, By Oral (2021-2030) ($MN)
  • Table 63 Global Pharmaceutical Excipients Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 64 Global Pharmaceutical Excipients Market Outlook, By Topical (2021-2030) ($MN)
  • Table 65 Global Pharmaceutical Excipients Market Outlook, By Enteral (2021-2030) ($MN)
  • Table 66 Global Pharmaceutical Excipients Market Outlook, By Sublingual & Buccal (2021-2030) ($MN)
  • Table 67 Global Pharmaceutical Excipients Market Outlook, By Intramuscular (2021-2030) ($MN)
  • Table 68 Global Pharmaceutical Excipients Market Outlook, By Intravenous (2021-2030) ($MN)
  • Table 69 Global Pharmaceutical Excipients Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 70 Global Pharmaceutical Excipients Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 71 Global Pharmaceutical Excipients Market Outlook, By Retail Sales (2021-2030) ($MN)
  • Table 72 Global Pharmaceutical Excipients Market Outlook, By Direct Tender (2021-2030) ($MN)
  • Table 73 Global Pharmaceutical Excipients Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 74 Global Pharmaceutical Excipients Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 75 Global Pharmaceutical Excipients Market Outlook, By End User (2021-2030) ($MN)
  • Table 76 Global Pharmaceutical Excipients Market Outlook, By Academics (2021-2030) ($MN)
  • Table 77 Global Pharmaceutical Excipients Market Outlook, By Contract Formulators (2021-2030) ($MN)
  • Table 78 Global Pharmaceutical Excipients Market Outlook, By Pharmaceuticals Companies (2021-2030) ($MN)
  • Table 79 Global Pharmaceutical Excipients Market Outlook, By Research Organization (2021-2030) ($MN)
  • Table 80 Global Pharmaceutical Excipients Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

"